APO Research
Talk to an analyst

APO RESEARCH · REPORT

Midostaurin Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Midostaurin Drugs Market Outlook and Growth Opportunities 2026

22 December 2025194 pages

Choose your research edition.

Industry ResearchMidostaurin Drugs Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal Midostaurin Drugs Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Midostaurin Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032171 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Midostaurin Drugs Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Midostaurin Drugs Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Midostaurin Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Midostaurin Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Midostaurin Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Midostaurin Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Midostaurin Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Midostaurin Drugs market include Novartis. among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Midostaurin Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Midostaurin Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Midostaurin Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Midostaurin Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Midostaurin Drugs Segment by Company

Novartis

Midostaurin Drugs Segment by Type

MDS

AML

Other

Midostaurin Drugs Segment by Application

Hospital

Pharmacy

Midostaurin Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Midostaurin Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Midostaurin Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Midostaurin Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Midostaurin Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Midostaurin Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Midostaurin Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Midostaurin Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Midostaurin Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Midostaurin Drugs industry.

Chapter 3: Detailed analysis of Midostaurin Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Midostaurin Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Midostaurin Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Midostaurin Drugs Industry Trends Table 2. Midostaurin Drugs Industry Drivers Table 3. Midostaurin Drugs Industry Opportunities and Challenges Table 4. Midostaurin Drugs Industry Restraints Table 5. Global Midostaurin Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Midostaurin Drugs Revenue Share by Company (2021-2026) Table 7. Global Midostaurin Drugs Sales Volume by Company (units) & (2021-2026) Table 8. Global Midostaurin Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Midostaurin Drugs Average Price (US$/unit) of Company (2021-2026) Table 10. Global Midostaurin Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Midostaurin Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Midostaurin Drugs Company, Product Type & Application Table 13. Global Midostaurin Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Midostaurin Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of MDS Table 18. Significant Companies of AML Table 19. Significant Companies of Other Table 20. Global Midostaurin Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (units) Table 21. Global Midostaurin Drugs Sales Volume by Type (2021-2026) & (units) Table 22. Global Midostaurin Drugs Sales Volume by Type (2027-2032) & (units) Table 23. Global Midostaurin Drugs Sales Volume Share by Type (2021-2026) Table 24. Global Midostaurin Drugs Sales Volume Share by Type (2027-2032) Table 25. Global Midostaurin Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Midostaurin Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Midostaurin Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Midostaurin Drugs Sales Value Share by Type (2021-2026) Table 29. Global Midostaurin Drugs Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital Table 31. Significant Companies of Pharmacy Table 32. Global Midostaurin Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (units) Table 33. Global Midostaurin Drugs Sales Volume by Application (2021-2026) & (units) Table 34. Global Midostaurin Drugs Sales Volume by Application (2027-2032) & (units) Table 35. Global Midostaurin Drugs Sales Volume Share by Application (2021-2026) Table 36. Global Midostaurin Drugs Sales Volume Share by Application (2027-2032) Table 37. Global Midostaurin Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Midostaurin Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Midostaurin Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Midostaurin Drugs Sales Value Share by Application (2021-2026) Table 41. Global Midostaurin Drugs Sales Value Share by Application (2027-2032) Table 42. Global Midostaurin Drugs Sales by Region: 2021 VS 2025 VS 2032 (units) Table 43. Global Midostaurin Drugs Sales by Region (2021-2026) & (units) Table 44. Global Midostaurin Drugs Sales Market Share by Region (2021-2026) Table 45. Global Midostaurin Drugs Sales by Region (2027-2032) & (units) Table 46. Global Midostaurin Drugs Sales Market Share by Region (2027-2032) Table 47. Global Midostaurin Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Midostaurin Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Midostaurin Drugs Sales Value Share by Region (2021-2026) Table 50. Global Midostaurin Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Midostaurin Drugs Sales Value Share by Region (2027-2032) Table 52. Global Midostaurin Drugs Market Average Price (US$/unit) by Region (2021-2026) Table 53. Global Midostaurin Drugs Market Average Price (US$/unit) by Region (2027-2032) Table 54. Global Midostaurin Drugs Sales by Country: 2021 VS 2025 VS 2032 (units) Table 55. Global Midostaurin Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Midostaurin Drugs Sales by Country (2021-2026) & (units) Table 57. Global Midostaurin Drugs Sales Market Share by Country (2021-2026) Table 58. Global Midostaurin Drugs Sales by Country (2027-2032) & (units) Table 59. Global Midostaurin Drugs Sales Market Share by Country (2027-2032) Table 60. Global Midostaurin Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Midostaurin Drugs Sales Value Market Share by Country (2021-2026) Table 62. Global Midostaurin Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Midostaurin Drugs Sales Value Market Share by Country (2027-2032) Table 64. Novartis Company Information Table 65. Novartis Business Overview Table 66. Novartis Midostaurin Drugs Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Novartis Midostaurin Drugs Product Portfolio Table 68. Novartis Recent Development Table 69. Key Raw Materials Table 70. Raw Materials Key Suppliers Table 71. Midostaurin Drugs Distributors List Table 72. Midostaurin Drugs Customers List Table 73. Research Programs/Design for This Report Table 74. Authors List of This Report Table 75. Secondary Sources Table 76. Primary Sources List of Figures Figure 1. Midostaurin Drugs Product Image Figure 2. Global Midostaurin Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Midostaurin Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Midostaurin Drugs Sales (2021-2032) & (units) Figure 5. Global Midostaurin Drugs Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Midostaurin Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. MDS Image Figure 10. AML Image Figure 11. Other Image Figure 12. Global Midostaurin Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (units) Figure 13. Global Midostaurin Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Midostaurin Drugs Sales Volume Share by Type (2021-2032) Figure 15. Global Midostaurin Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Midostaurin Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Midostaurin Drugs Sales Value Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Pharmacy Image Figure 20. Global Midostaurin Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (units) Figure 21. Global Midostaurin Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Midostaurin Drugs Sales Volume Share by Application (2021-2032) Figure 23. Global Midostaurin Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Midostaurin Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Midostaurin Drugs Sales Value Share by Application (2021-2032) Figure 26. Global Midostaurin Drugs Sales by Region: 2021 VS 2025 VS 2032 (units) Figure 27. Global Midostaurin Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Midostaurin Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Midostaurin Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Midostaurin Drugs Sales Value (2021-2032) & (US$ Million) Figure 31. North America Midostaurin Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Midostaurin Drugs Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Midostaurin Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Midostaurin Drugs Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Midostaurin Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Midostaurin Drugs Sales Value (2021-2032) & (US$ Million) Figure 37. South America Midostaurin Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Midostaurin Drugs Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Midostaurin Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Midostaurin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Midostaurin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Midostaurin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Midostaurin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Midostaurin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Midostaurin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Midostaurin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Midostaurin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Midostaurin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Midostaurin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Midostaurin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Midostaurin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Midostaurin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Midostaurin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Midostaurin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Midostaurin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Midostaurin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Midostaurin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Midostaurin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Midostaurin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Midostaurin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Midostaurin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Midostaurin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Midostaurin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Midostaurin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Midostaurin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Midostaurin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Midostaurin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Midostaurin Drugs Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Midostaurin Drugs Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • MDS
  • AML
  • Other
Applications
  • Hospital
  • Pharmacy
Companies covered
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Midostaurin Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Midostaurin Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Midostaurin Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Midostaurin Drugs Market Dynamics
  1. 2.1 Midostaurin Drugs Industry Trends
  2. 2.2 Midostaurin Drugs Industry Drivers
  3. 2.3 Midostaurin Drugs Industry Opportunities and Challenges
  4. 2.4 Midostaurin Drugs Industry Restraints
3 Midostaurin Drugs Market by Company
  1. 3.1 Global Midostaurin Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Midostaurin Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Midostaurin Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Midostaurin Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Midostaurin Drugs Company Ranking (2024-2026)
  6. 3.6 Global Midostaurin Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Midostaurin Drugs Company Product Type and Application
  8. 3.8 Global Midostaurin Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Midostaurin Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Midostaurin Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Midostaurin Drugs Market by Type
  1. 4.1 Midostaurin Drugs Type Introduction
  2. 4.1.1 MDS
  3. 4.1.2 AML
  4. 4.1.3 Other
  5. 4.2 Global Midostaurin Drugs Sales Volume by Type
  6. 4.2.1 Global Midostaurin Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Midostaurin Drugs Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Midostaurin Drugs Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Midostaurin Drugs Sales Value by Type
  10. 4.3.1 Global Midostaurin Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Midostaurin Drugs Sales Value by Type (2021-2032)
  12. 4.3.3 Global Midostaurin Drugs Sales Value Share by Type (2021-2032)
5 Midostaurin Drugs Market by Application
  1. 5.1 Midostaurin Drugs Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Pharmacy
  4. 5.2 Global Midostaurin Drugs Sales Volume by Application
  5. 5.2.1 Global Midostaurin Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Midostaurin Drugs Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Midostaurin Drugs Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Midostaurin Drugs Sales Value by Application
  9. 5.3.1 Global Midostaurin Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Midostaurin Drugs Sales Value by Application (2021-2032)
  11. 5.3.3 Global Midostaurin Drugs Sales Value Share by Application (2021-2032)
6 Midostaurin Drugs Regional Sales and Value Analysis
  1. 6.1 Global Midostaurin Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Midostaurin Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Midostaurin Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Midostaurin Drugs Sales by Region (2027-2032)
  5. 6.3 Global Midostaurin Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Midostaurin Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Midostaurin Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Midostaurin Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Midostaurin Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Midostaurin Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Midostaurin Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Midostaurin Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Midostaurin Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Midostaurin Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Midostaurin Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Midostaurin Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Midostaurin Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Midostaurin Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Midostaurin Drugs Sales Value Share by Country, 2025 VS 2032
7 Midostaurin Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Midostaurin Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Midostaurin Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Midostaurin Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Midostaurin Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Midostaurin Drugs Sales by Country (2027-2032)
  6. 7.4 Global Midostaurin Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Midostaurin Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Midostaurin Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Midostaurin Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Midostaurin Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Midostaurin Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Midostaurin Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Midostaurin Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Midostaurin Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Midostaurin Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Midostaurin Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Midostaurin Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Midostaurin Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Midostaurin Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Midostaurin Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Midostaurin Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Midostaurin Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Midostaurin Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Midostaurin Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Midostaurin Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Midostaurin Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Midostaurin Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Midostaurin Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Midostaurin Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Midostaurin Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Midostaurin Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Midostaurin Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Midostaurin Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Midostaurin Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Midostaurin Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Midostaurin Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Midostaurin Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Midostaurin Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Novartis
  2. 8.1.1 Novartis Company Information
  3. 8.1.2 Novartis Business Overview
  4. 8.1.3 Novartis Midostaurin Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Novartis Midostaurin Drugs Product Portfolio
  6. 8.1.5 Novartis Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Midostaurin Drugs Value Chain Analysis
  2. 9.1.1 Midostaurin Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Midostaurin Drugs Sales Mode & Process
  6. 9.2 Midostaurin Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Midostaurin Drugs Distributors
  9. 9.2.3 Midostaurin Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst